Baxter International Management
Management criteria checks 2/4
Baxter International's CEO is David Shafer, appointed in Feb 2025, has a tenure of 2.75 years. directly owns 0.003% of the company’s shares, worth $417.01K. The average tenure of the management team and the board of directors is 1.7 years and 3.6 years respectively.
Key information
David Shafer
Chief executive officer
US$382.3k
Total compensation
CEO salary percentage | n/a |
CEO tenure | no data |
CEO ownership | 0.003% |
Management average tenure | 1.7yrs |
Board average tenure | 3.6yrs |
Recent management updates
Recent updates
Baxter International: An Uncompelling Investment With High Debt
Jan 31Does Baxter International (NYSE:BAX) Have A Healthy Balance Sheet?
Jan 27Is Baxter International Inc. (NYSE:BAX) Trading At A 49% Discount?
Sep 05Baxter- Reiterating Our Buy Rating After A Promising Q2
Aug 07Baxter International (NYSE:BAX) Will Pay A Dividend Of $0.29
Aug 07Baxter International (NYSE:BAX) Has Affirmed Its Dividend Of $0.29
Jul 23Baxter: Why Investors Should Take Advantage Of The Low Valuation
Jul 16Little Excitement Around Baxter International Inc.'s (NYSE:BAX) Revenues
Jul 12Baxter International (NYSE:BAX) Has Affirmed Its Dividend Of $0.29
May 30Baxter International (NYSE:BAX) Is Due To Pay A Dividend Of $0.29
May 14Baxter International: Shares Too Cheap, EPS Growth Ahead With A Possible Spinoff
May 08Capital Allocation Trends At Baxter International (NYSE:BAX) Aren't Ideal
Apr 14Broyhill - Baxter International: Renal Care Spin-Off And Recent Revamp Should Provide Catalysts
Feb 23Baxter International's (NYSE:BAX) Dividend Will Be $0.29
Feb 20Baxter International: A Cheap Big Pharma Stock With Improving Earnings And +3% Dividend Yield
Dec 12Should You Buy Baxter Or DaVita After The Fallout From The Ozempic Trial?
Oct 12Dividend Challengers Review: Baxter International
Aug 14Baxter International: Hillrom Acquisition Could Be A Tailwind For FCF
Jun 12CEO
David Shafer (67 yo)
no data
Tenure
US$382,310
Compensation
Mr. David Brent Shafer serves as Director of Veracyte, Inc. since September 2024. He is Director of Tactile Systems Technology, Inc. from January 05, 2022. He had been Chairman and Chief Executive Officer...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chair & Interim CEO | no data | US$382.31k | 0.0027% $ 417.0k | |
Executive VP | 1.3yrs | US$5.37m | 0.0028% $ 435.9k | |
Executive Vice President & COO | no data | US$4.86m | 0.031% $ 4.9m | |
Advisor | no data | US$13.79m | 0.11% $ 17.5m | |
Executive VP & Group President of Pharmaceuticals | 2.6yrs | US$3.87m | 0.0024% $ 371.4k | |
Senior VP and Chief Medical & Scientific Officer | 2.1yrs | no data | no data | |
Senior VP & Chief Information Officer | less than a year | no data | no data | |
Vice President of Investor Relations | no data | no data | no data | |
Executive VP & General Counsel | 2.8yrs | US$5.66m | 0.0018% $ 284.8k | |
Senior Vice President | no data | no data | no data | |
Executive VP & Chief Human Resources Officer | 7.8yrs | US$4.14m | 0.037% $ 5.8m | |
Executive VP & Chief Supply Chain Officer | 5.1yrs | no data | 0.0036% $ 564.9k |
1.7yrs
Average Tenure
61yo
Average Age
Experienced Management: BAX's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chair & Interim CEO | 2.8yrs | US$382.31k | 0.0027% $ 417.0k | |
Independent Director | 1.5yrs | US$197.82k | 0.0018% $ 280.1k | |
Independent Director | 8yrs | US$373.98k | 0.0055% $ 859.2k | |
Independent Director | 6yrs | US$364.98k | 0.0042% $ 657.8k | |
Lead Independent Director | 3.2yrs | US$363.00k | 0.0028% $ 440.6k | |
Independent Director | 8.1yrs | US$367.31k | 0.0044% $ 695.5k | |
Director | less than a year | no data | 0.00068% $ 107.0k | |
Independent Director | 4yrs | US$357.00k | 0.0032% $ 502.0k | |
Independent Director | 1.7yrs | US$226.35k | 0.0019% $ 303.7k | |
Independent Director | 6yrs | US$352.98k | no data |
3.6yrs
Average Tenure
66yo
Average Age
Experienced Board: BAX's board of directors are considered experienced (3.6 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/02/16 05:08 |
End of Day Share Price | 2025/02/14 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Baxter International Inc. is covered by 45 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Jasper Hellweg | Argus Research Company |
Benjamin Yeoh | Atlantic Equities LLP |
Daniel Owczarski | Avondale Partners |